Prospects for prevention of vertical transmission of human immunodeficiency virus by immunization.

about

Prospects for prevention of vertical transmission of human immunodeficiency virus by immunization.

Item

http://www.wikidata.org/entity/Q40793604

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年学术文章

@wuu

1993年学术文章

@zh-cn

1993年学术文章

@zh-hans

1993年学术文章

@zh-my

1993年学术文章

@zh-sg

1993年學術文章

@yue

1993年學術文章

@zh

1993年學術文章

@zh-hant

name

Prospects for prevention of ve ...... iciency virus by immunization.

@en

type

Item

label

Prospects for prevention of ve ...... iciency virus by immunization.

@en

prefLabel

Prospects for prevention of ve ...... iciency virus by immunization.

@en

P1476

Prospects for prevention of ve ...... iciency virus by immunization.

@en

P2093

Althaus B

http://www.w3.org/2001/XMLSchema#string

Cryz SJ Jr

http://www.w3.org/2001/XMLSchema#string

Fürer E

http://www.w3.org/2001/XMLSchema#string

Goldstein H

http://www.w3.org/2001/XMLSchema#string

Hasler T

http://www.w3.org/2001/XMLSchema#string

Que JU

http://www.w3.org/2001/XMLSchema#string

Rubinstein A

http://www.w3.org/2001/XMLSchema#string

P2860

Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain.

Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers.

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus.

Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humans.

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein.

P304

194-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.1993.TB26268.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

693

http://www.w3.org/2001/XMLSchema#string

P577

1993-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8267263

http://www.w3.org/2001/XMLSchema#string